Need for a New Trial to Evaluate Adjuvant Postoperative Radiotherapy in Non–Small-Cell Lung Cancer Patients With N2 Mediastinal Involvement-Reference-Cited by-同舟云学术

Need for a New Trial to Evaluate Adjuvant Postoperative Radiotherapy in Non–Small-Cell Lung Cancer Patients With N2 Mediastinal Involvement

Published:2007-03-01 Issue:7 Volume:25 Page:e10-e11
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Le Péchoux Cecile¹,Dunant Ariane¹,Pignon Jean-Pierre¹,De Ruysscher Dirk²,Mornex Françoise³,Senan Suresh⁴,Casas Francesc⁵,Price Allan⁶,Milleron Bernard⁷

Affiliation:

1. Departments of Radiotherapy and Biostatistics, Institut Gustave Roussy, Villejuif, France

2. Academic Hospital Maastricht/GROW/MAASTRO Clinic, Maastricht, the Netherlands

3. Department of Radiotherapy-Oncology, Centre Hospitalier Lyon Sud, Lyon, France

4. Department of Radiation Oncology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands

5. Department of Radiation Oncology, Institut Clinic de Malalties Oncohematologiques, Hospital Clinic i Universitari, Barcelona, Spain

6. Department of Oncology, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom

7. Pneumology Unit, Tenon University Hospital, Paris, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.09.6263

Reference11 articles.

1. Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database

2. Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

3. Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

4. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

5. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications and Parameters Around Postoperative Radiation Therapy for Lung Cancer;Journal of Clinical Oncology;2022-02-20

2. Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question;Translational Lung Cancer Research;2021-04

3. Prognostic value of visceral pleural invasion in the stage pT1-2N2M0 non-small cell lung cancer: A study based on the SEER registry;Current Problems in Cancer;2021-02

4. Heterogeneity of stage IIIA non-small cell lung cancer—different tumours, different nodal status, different treatment, different prognosis: a narrative review;Current Challenges in Thoracic Surgery;2021-01

5. Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review;Translational Lung Cancer Research;2020-10